Analysts Think Axsome Therapeutics Stock Could Soar 35% Over the Next 12 Months. Is the Stock a No-Brainer Buy? The Motley Fool 4d
Axsome Therapeutics vs. Revolution Medicines: Which Healthcare Stock Is a Better Buy in 2026? The Motley Fool 4d
Axsome Therapeutics (AXSM) Unveils New Depression And Alzheimer’s Agitation Data At Psych Congress 2026 Simply Wall St 5d
Anixa Biosciences Granted First Australian Patent for its Breast Cancer Vaccine, Broadening Global Protection Through 2040 PR Newswire (Press Release) 1d Patent Law Intellectual Property Ohio
Virtual biotech company puts 37,000 AI agents to work on drug discovery Singularity Hub 4d AI Biotech Pharma
Bioshanghai week 2026 opens -- Joining forces to build a Global biopharmaceutical innovation ecosystem PR Newswire (Press Release) 3d China Politics Biotech
Ultragenyx pharmaceutical (rare) stock jumps after hours: Here's why it is trending Benzinga 5d Pharma Article paywall
District of Massachusetts dismisses putative Class Action against gene therapy company for failure to adequately allege... JD Supra 4h Massachusetts FDA Biotechnology
Dompé settlement highlights DOJ's continued scrutiny of Pharmaceutical manufacturer donations to patient assistance foundations JD Supra 5h FDA
Insurance coverage lags as cancer science, treatment move forward Kaiser Health News 14h Cancer Cancer Treatment Global Health
